Streetbeat News

Regulatory

SPY

VGK

The Kremlin announced that Russia is ready for further arms control talks, according to Reuters citing IFX.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 3:35 pm

TSLA

Elon Musk, at VivaTech, reiterated his call for AI regulation, emphasizing the potential negative consequences of digital superintelligence. He urged governments to take action before it's too late.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 2:52 pm

STXS

Stereotaxis announced its intention to initiate a trial for CE Mark submission for its MAGiC catheter. The European Notified Body requested clinical data to support the submission, causing STXS shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 2:43 pm

SPY

VGK

Russian President Vladimir Putin stated that the use of nuclear weapons is theoretically possible in case of danger to Russia's territory, but there is no current need. He also mentioned that Russia has more nuclear weapons than NATO.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 2:39 pm

SPY

VGK

Russian President Vladimir Putin stated that Russia could destroy parts of central Kyiv in response to 'provocations' but has chosen not to do so for various reasons.

Portfolio Pulse from Benzinga Newsdesk

June 16, 2023 | 2:35 pm

SPY

The University of Michigan consumer sentiment reading increased by 8% in June, surpassing forecasts, as concerns about the debt ceiling crisis faded and optimism grew due to a strong labor market and elevated stock market gains. Inflation expectations for the next year dropped to 3.2%, the lowest since March 2021.

Portfolio Pulse from Piero Cingari

June 16, 2023 | 2:27 pm

BLK

BlackRock has filed an application with the SEC to launch a publicly traded Bitcoin ETF, the iShares Bitcoin Trust, with Coinbase Custody Trust Co. as its custodian partner. This comes after BlackRock CEO Larry Fink's 2017 comment calling Bitcoin an 'index of money laundering'.

Portfolio Pulse from Mehab Qureshi

June 16, 2023 | 2:25 pm

RHHBY

The FDA has granted accelerated approval to Roche's Columvi (glofitamab-gxbm) for the treatment of relapsed or refractory diffuse large B-cell lymphoma and large B-cell lymphoma arising from follicular lymphoma. The approval is based on the phase 1/2 NP30179 study results, which showed durable remission in patients treated with fixed-duration Columvi.

Portfolio Pulse from Vandana Singh

June 16, 2023 | 2:16 pm

NKLA

Nikola Corp (NASDAQ:NKLA) shares are trading higher by 15% to $1.61 on heavy volume and amid overall market strength. The EV maker gained last week after shareholders rejected the company's proposal to issue more stock shares. The International Energy Agency predicts global oil demand could peak before the end of this decade, which may benefit EV makers like Nikola.

Portfolio Pulse from Henry Khederian

June 16, 2023 | 2:13 pm